Israel is emerging as the world’s leader in vaccinating its population, and seeing results in declines of new Covid-19 cases. . . . → Read More: Infographic – Israel Halts Covid-19 Spread with Vaccines
|
|||||
|
       
  |
Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance 
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial 
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients. . . . → Read More: Antibody Cocktail Prevents Covid-19 Disease Symptoms 
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease. . . . → Read More: Arthritis Drug Unsuccessful for Covid-19 Hospital Patients 
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response. . . . → Read More: NIH Trial Testing mRNA Vaccine Allergic Effects 
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds 
Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers. . . . → Read More: Trial Shows Inhaled Covid-19 Therapy Safe 
Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries  Comments are closed  Joint ventures/collaborations  biomedical, biotechnology, Covid-19, India, Korea, manufacturing, pharmaceuticals 
A clinical trial shows a treatment targeting gut microbes reduces health care use and recovery times in people with mild to moderate Covid-19 disease. . . . → Read More: Microbiome Therapy Shown to Cut Covid-19 Health Needs One comment - (Comments are closed) New products biomedical, chemistry, clinical trials, Covid-19, life sciences, pharmaceuticals, physical sciences |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||